What is the current best drug treatment for hypertensive heart failure with preserved ejection fraction? Review of the totality of evidence
K Sevre, A Rist, K Wachtell, RB Devereux… - American Journal of …, 2024 - academic.oup.com
BACKGROUND More than 90% of patients developing heart failure (HF) have an
epidemiological background of hypertension. The most frequent concomitant conditions are …
epidemiological background of hypertension. The most frequent concomitant conditions are …
[HTML][HTML] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European journal of …, 2023 - Elsevier
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
Management of hypertension in chronic heart failure
S Manickavasagam, R Merla, MM Koerner… - Expert Review of …, 2009 - Taylor & Francis
Chronic heart failure (CHF) is associated with frequent hospitalizations and high mortality. It
affects more than 5 million individuals in the USA, and another 660,000 new cases are …
affects more than 5 million individuals in the USA, and another 660,000 new cases are …
Hypertension and heart failure with preserved ejection fraction: connecting the dots
C Tsioufis, G Georgiopoulos… - Current Vascular …, 2018 - ingentaconnect.com
Introduction: Heart failure (HF) with preserved ejection fraction (EF)(HFpEF) accounts for
approximately 50% of HF cases and its prevalence relative to HF with reduced EF is rising …
approximately 50% of HF cases and its prevalence relative to HF with reduced EF is rising …
CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction
M McDonald, S Virani, M Chan, A Ducharme… - Canadian Journal of …, 2021 - Elsevier
In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we
provide comprehensive recommendations and practical tips for the pharmacologic …
provide comprehensive recommendations and practical tips for the pharmacologic …
Treatment of heart failure with normal ejection fraction
Opinion Statement Heart failure (HF) is a major cause of mortality and morbidity and one of
the most frequent reasons for hospital admission in the United States and Europe. Currently …
the most frequent reasons for hospital admission in the United States and Europe. Currently …
Heart failure with reduced ejection fraction: a review
Importance Worldwide, the burden of heart failure has increased to an estimated 23 million
people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF) …
people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF) …
Health equity in heart failure
A Vijay, CW Yancy - Progress in Cardiovascular Diseases, 2024 - Elsevier
The treatment of heart failure (HF) with reduced ejection fraction (HFrEF) has substantially
developed over the past decades. More than ever before, the application of appropriate …
developed over the past decades. More than ever before, the application of appropriate …
[HTML][HTML] Management of hypertension associated with cardiovascular failure
S Kiuchi, T Ikeda - Journal of Cardiology, 2022 - Elsevier
Hypertension (HT) treatment should focus on the prevention of new-onset heart failure (HF)
or its exacerbation due to the increasing trend of HF incidence in Japan. According to the …
or its exacerbation due to the increasing trend of HF incidence in Japan. According to the …
Evidence-based therapy for heart failure
PC Deedwania, E Carbajal - Medical Clinics, 2012 - medical.theclinics.com
Heart failure (HF) is a major public health problem, and it is associated with increased
morbidity and mortality. As the US life expectancy increases and the population ages, the …
morbidity and mortality. As the US life expectancy increases and the population ages, the …